Skip to content

Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02188095
Enrollment
100
Registered
2014-07-11
Start date
2014-09-03
Completion date
2025-11-07
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthritis

Brief summary

Clinical and radiological 10 year results of Excia T® Hip Stem

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient gave written informed consent * age ≥ 18 years

Exclusion criteria

* pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Survival Rate of the Implant10 yearsKaplan-Meier Survival Rate up to 10 years

Secondary

MeasureTime frameDescription
Change of functional outcome over follow-up period (Harris Hip Score (HHS))at discharge, after 3 and 12 months 3, 5 and 10 yearsThe Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities.
Hip disability and Osteoarthritis Outcome Score (HOOS)preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 yearsDocumentation of clinical outcome with HOOS Score
Shaftposition ap and lateral10 yearsRadiological documentation of shaftposition in ap and lateral view discharge, after 3 and 12 months and 3, 5, and 10 years
Stress Shielding10 yearsRadiological documentation of stress shielding after 3 and 12 months and 3, 5, and 10 years
Hypertrophies10 yearsRadiological documentation of hypertrophies after 3 and 12 months and 3, 5, and 10 years
Pain Assessmentat 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)Pain will be measured with a Visual Analogue Scale (VAS), at rest and when walking on flat ground. The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patients are asked to mark their current pain level on the line.

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORPeter Aldinger, Prof. Dr.

Diakonie-Klinikum Stuttgart

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026